[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Article
January 1990

Elevated Tumor Necrosis Factorα Production Concomitant to Elevated Prostaglandin E2 Production by Trauma Patients' Monocytes

Author Affiliations

From the Departments of Surgery (Drs Takayama, Miller, and Szabo) and Molecular Genetics and Microbiology (Drs Miller and Szabo), University of Massachusetts Medical Center, Worcester.

Arch Surg. 1990;125(1):29-35. doi:10.1001/archsurg.1990.01410130031004
Abstract

• The level of tumor necrosis factorα (TNFα), a monokine implicated in mediating septic shock, is elevated in the blood of some patients with sepsis. Monocytes from 11 trauma patients and 11 burn patients were suboptimally stimulated with interferon gamma and muramyl dipeptide, an analogue of bacterial wall products. The patients with sepsis showed significantly greater total TNFα levels (secreted in combination with cell-associated) 3 days before septic episodes, as compared with normal controls (32.38 to 2231.76 ng/106 monocytes per milliliter, median = 121.03 ng/106 monocytes per milliliter; normal control: 0.00 to 18.20 ng/106 monocytes per milliliter, median = 5.93 ng/106 monocytes per milliliter). Increases in patients' total monocyte TNFα levels greater than 30 ng/106 monocytes per milliliter correlated with septic episodes. In patients with sepsis, the total monocyte TNFlevels were increased despite a concomitant increase in their prostaglandin E2 levels in both stimulated (interferon gamma plus muramyl dipeptide) and unstimulated in vitro assays (9 patients: stimulated prostaglandin E2 range, 30.1 to 123.6 ng/106 monocytes per milliliter). Massively elevated monocyte TNFα and prostaglandin E2 production occurred simultaneously in patients with sepsis.

(Arch Surg. 1990;125:29-35)

References
1.
Tracey KJ, Beutler B, Lowry SF, et al.  Shock and tissue induced by recombinaht human cachectin . Science . 1986;234:470-474.Article
2.
Moldawer LL, Lowry SF, Cerami A.  Cachectin: its impact on metabolism and nutritional status . Ann Rev Nutr . 1988;8:585-609.Article
3.
Tracey KJ, Fong Y, Hesse DG, et al.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia . Nature . 1987;330:662-664.Article
4.
Reuter A, Bernier J, Gysen P, et al.  An RIA for tumor necrosis factor (TNF,) and interleukin-a beta (IL-1.) and their direct determination in serum . In: Powanda MC, Oppenheim JJ, Kluger MJ, Dinarello CA, eds. Monokines and Other Nonlymphocytic Cytokines . New York, NY: Alan R Liss Ine; 1988:3773-3781.
5.
Miller-Graziano C, Szabo G, Takayama T, Wu J.  Alterations of monocyte function following major surgery . In: Faist E, ed. The Immune Consequences of Trauma, Shock, and Sepsis . Berlin, West Germany: Karl Demeter Verlag; 1989:9-16.
6.
Latter DA, Tchervenkov JI, Nohr CW, Christou NV.  The effect of indomethacin on burn-induced immunosuppression . J Surg Res . 1987;43:246-252.Article
7.
Faist E, Mewes A, Strasser T, et al.  Alteration of monocyte function following major surgery . Arch Surg . 1988;23:287-292.Article
8.
Miller-Graziano CL, Fink M, Wu JY, Szabo G, Kodys K.  Mechanisms of altered monocyte prostaglandin E2 production in severely injured patients . Arch Surg . 1988;123:293-299.Article
9.
Kunkel SL, Scales WE, Spengler R, Spengler M, Larrick J.  Dynamics and regulation of macrophage tumor necrosis factor-α (TNF), interleukin-1-α(IL-lα) and interleukin-1-β (IL-lβ) gene expression by arachidonate metabolites . In: Powanda MC, Oppenheim JJ, Kluger MJ, Dinarello CA, eds. Monokines and Other Nonlymphocytic Cytokines . New York, NY: Alan R Liss Inc; 1988:61-66.
10.
Le J, Vilcek J.  Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities . Lab Invest . 1987;56:234-248.
11.
Kriegler M, Perez C, DeFay K, Alber I, Lu SD.  A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF . Cell . 1988;53:45-53.Article
12.
Debets JM, Van der Linden CJ, Dieteren IE, Leeuwenburg JF, Burman WA.  Fc-receptor cross-linking induces rapid secretion of tumor necrosis factor (cachectin) by human peripheral blood monocytes . J Immunol . 1988;141:1197-1201.
13.
Barna BP, James K, Deodhar SD.  Activation of human monocyte tumoricidal activity by C-reactive protein . Cancer Res . 1987;47:3959-3963.
14.
Herriott MJ, Leu RW.  Activation of mouse macrophages for migration inhibition and for tumor cytotoxicity if mediated by interferon gamma priming and triggering by various agents . J Interferon Res . 1987;7:165-171.Article
15.
Kunkel SL, Spengler M, Kwon G, May MA, Remick DG.  Production and regulation of tumor necrosis factor alpha . Methods Achiev Exp Pathol . 1988;13:240-259.
16.
Renz H, Gong JH, Schmidt A, Nain M, Gemsa D.  Release of tumor necrosis factor alpha from macrophages: enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides . J Immunol . 1988;141:2388-2393.
17.
Pace JL, Russel SW.  Gamma interferon interferes with the negative regulation of macrophage activation by prostaglandin E2 . Mol Immunol . 1984;21:249-254.Article
18.
Taffet SM.  Regulation ofthe TNF gene expression by lipopolysaccharide cyclic AMP and interferon . In: Powanda MC, Oppenheim JJ, Kluger MJ, Dinarello CA, eds. Monokines and Other Nonlymphocytic Cytokines . New York, NY: Alan R Liss Inc; 1988:67-72.
19.
Nijsten MWN, deGroot ER, tenDuis HJ, Klasen HJ, Hack CE, Aarden LA.  Serum levels of interleukin-6 and acute phase responses . Lancet . 1987;2:921.Article
×